Compare CNSP & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNSP | AMST |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 7.4M |
| IPO Year | 2019 | 2020 |
| Metric | CNSP | AMST |
|---|---|---|
| Price | $5.23 | $0.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 8.2K | ★ 104.2K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 8.03 | ★ 40.46 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $110,459.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.90 | $0.77 |
| 52 Week High | $10.59 | $4.78 |
| Indicator | CNSP | AMST |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 36.20 |
| Support Level | $5.15 | $0.88 |
| Resistance Level | $5.53 | $2.10 |
| Average True Range (ATR) | 0.43 | 0.08 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 52.76 | 10.24 |
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.